The disconnect between animal models of sepsis and human sepsis
- 4 October 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 81 (1) , 137-143
Abstract
Frequently used experimental models of sepsis include cecal ligation and puncture, ascending colon stent peritonitis, and the i.p. or i.v. injection of bacteria or bacterial products (such as LPS). Many of these models mimic the pathophysiology of human sepsis. However, identification of mediators in animals, the blockade of which has been protective, has not translated into clinical efficacy in septic humans. We describe the shortcomings of the animal models and reasons why effective therapy for human sepsis cannot be derived readily from promising findings in animal sepsis.Keywords
Funding Information
- National Institutes of Health (GM-29507, HL-31963, GM-61656)
This publication has 70 references indexed in Scilit:
- Distance of Cecum Ligated Influences Mortality, Tumor Necrosis Factor-Alpha and Interleukin-6 Expression following Cecal Ligation and Puncture in the RatEuropean Surgical Research, 2003
- Lipopolysaccharide Dose Response in BaboonsShock, 2003
- Response of Anticoagulant Pathways in Disseminated Intravascular CoagulationSeminars in Thrombosis and Hemostasis, 2001
- Immune Response and Cytokines in Septic Rats Undergoing Blood TransfusionJournal of Surgical Research, 1998
- IMMUNE DYSFUNCTION IN MURINE POLYMICROBIAL SEPSISShock, 1996
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992
- Animal Model for Chronic-Abscess-Forming Peritonitis: Histology and MicrobiologyEuropean Surgical Research, 1990
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987